Rosai dorfman disease of the orbit

dc.contributor.author Vemuganti, Geeta K.
dc.contributor.author Naik, Milind N.
dc.contributor.author Honavar, Santosh G.
dc.date.accessioned 2022-03-27T04:10:46Z
dc.date.available 2022-03-27T04:10:46Z
dc.date.issued 2008-12-01
dc.description.abstract Objective: To report the clinico-histopathologic features, management and outcome of RosaiDorfman disease of the orbit. Design: Non-comparative case series. Results: Rosai-Dorfman disease of the orbit constituted 0.09% of all ocular specimens received at our Institute, presenting with a firm rubbery mass causing proptosis; bilateral in 4 (57%) cases. The median age at presentation was 13 years (range 5-65); median duration of symptoms was 6 (range 3-15) years. Lymphadenopathy was noted in 4 (57%); extranodal involvement in 3 (43%). After biopsy, 3 cases were treated with systemic corticosteroids, 2 cases developed local recurrence that responded to systemic corticosteroid therapy. Polymorphous population of lymphocytes, plasma cells, and characteristic S-100-positive histiocytes showing emperipolesis were pathognomonic histologic features. Conclusion: Rosai-Dorfman disease of the orbit, although rare, should be considered in young individuals with chronic proptosis with rubbery masses. Excision and corticosteroid therapy provide a favorable outcome. © 2008 Vemuganti et al.
dc.identifier.citation Journal of Hematology and Oncology. v.1(1)
dc.identifier.uri 10.1186/1756-8722-1-7
dc.identifier.uri https://jhoonline.biomedcentral.com/articles/10.1186/1756-8722-1-7
dc.identifier.uri https://dspace.uohyd.ac.in/handle/1/6579
dc.title Rosai dorfman disease of the orbit
dc.type Journal. Article
dspace.entity.type
Files
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Plain Text
Description: